title: Improving the analysis and modeling of substance use.
authors.affiliation: a Department of Psychiatry , University of Maryland School of Medicine , Baltimore , MD .
authors.forename: David A
authors.initials: DA
authors.lastname: Gorelick
authors.affiliation: b Program of Excellence in Addictions Research, Washington State University , Spokane , WA , and.|c Providence Medical Research Center, Providence Sacred Heart Medical Center , Spokane , WA , USA.
authors.forename: Sterling
authors.initials: S
authors.lastname: McPherson
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects*; D003627:Data Interpretation, Statistical; D017831:Diagnosis, Dual (Psychiatry) / Q000706:statistics & numerical data*; D005260:Female; D005544:Forecasting; D006291:Health Policy; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects*; D008297:Male; D001523:Mental Disorders / Q000150:complications* / Q000453:epidemiology*; D015233:Models, Statistical; D009293:Opioid-Related Disorders / Q000401:mortality* / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D016540:Smoking Cessation; D016008:Statistical Distributions; D019966:Substance-Related Disorders / Q000150:complications* / Q000453:epidemiology*; D061485:Tobacco Use Cessation Devices
chemical_list: D000701:Analgesics, Opioid; D013287:Illicit Drugs